Shots: The company expands its portfolio with the marketing of the 6th biosimilars in Canada. Inclunox and Inclunox HP (enoxaparin sodium solution for injection) is indicated for use in 6 indications of the reference Lovenox and Lovenox HP in oncology, immunology, and endocrinology Sandoz Canada has completed the pCPA negotiations for Inclunox and Inclunox HP, […]Read More
Shots: The company reports the availability of Amgevita, referencing Humira to treat 11 chronic inflammatory conditions in Canada Amgevita is available as a prefilled syringe and a prefilled pen (SureClick autoinjector) with a broad range of pack sizes to support dosing for each indication and available in a citrate-free formulation. Amgevita is reimbursed on the […]Read More
Shots: The company has launched the first virtual clinic to guide patients with chronic conditions and helps to improve health and behavior via tracking tools & informational guides for weight management, daily activity levels and more Omada’s platform uses AI to analyze movements and range of motion via video and offers physical therapy sessions, wearable […]Read More
Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 and 700 series insulin pumps The extended infusion set utilizes advanced materials that help in reducing insulin preservative loss and maintains its flow & stability. The new tubing connector improves […]Read More
Shots: Valeo has started commercial shipment of Redesca and Redesca HP, its low molecular weight heparin (“LMWH”) biosimilar across Canada The LMWH is being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism and is now increasingly used as a 1L of defense tool in the fight against COVID-19 Redesca is a […]Read More
Shots: FormularyDecisions’ new feature will provide registered users with centralized access to pertinent product and drug pipeline information, regulatory guidance and state-specific substitution laws The biosimilar hub will provide users an interactive chart of the US biosimilar market landscape, curated biosimilar resources and dynamic repository of state substitution laws for biosimilar products With the hub, […]Read More
Shots: Roche launches Elecsys EBV immunoassay panel in countries accepting the CE mark. The Elecsys EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA IgG, and Elecsys EBV EBNA IgG to detect Abs specific for the infection stage The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood […]Read More
Shots: Roche launches eight new configurations for Cobas pro integrated solutions in countries accepting the CE mark and is designed to address the individual needs to maximize throughput and efficiency Cobas pro integrated solutions can deliver up to 4,400 tests/ hr., doubling its previous testing capacity. The addition of the new configurations allows labs to […]Read More
Shots: The new peptide MAM workflow for the BioAccord LC-MS system that helps to monitor critical quality attributes of protein-based drugs that can affect the safety & efficacy of innovator drugs and biosimilars By integrating BioAccord system on the waters_connect platform, scientists have a sensitive multiplexed method to accurately assess the attributes of protein-based drugs […]Read More
Shots: The coalition builds on Abbott’s excellence in virus surveillance and aid in analyzing virus samples for unknown diseases and detects mutations and variants including COVID-19 The goal of the Pandemic Defense Coalition is to identify new pathogens, analyze potential risk level, assess public health impact in real-time, and contain outbreaks when new virus threats […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
